CCL17 and neoplasm: Furthermore, a CCL17/22-rich milieu orchestrated by myeloid cells leads to local nTreg chemoattraction, which has been shown to enable tumor immune evasion, prevent autoimmune diabetes and promote donor-specific tolerance (31–34).